Iovance Biotherapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 08/07/2026 | 36.96 M | $153.74 M | 18.91% | 8.21% |
| MHR FUND MANAGEMENT LLC | 08/14/2026 | 28.97 M | $120.50 M | 0.00% | 6.43% |
| STATE STREET CORP | 09/22/2026 | 24.48 M | $101.83 M | 40.29% | 5.44% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 19.01 M | $79.08 M | 38.89% | 4.22% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 18.20 M | $75.73 M | 9.55% | 4.04% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 14.39 M | $59.86 M | 22.97% | 3.20% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 10.32 M | $42.96 M | 20.44% | 2.29% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 8.53 M | $35.47 M | -9.44% | 1.89% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 6.46 M | $26.88 M | 144.19% | 1.44% |
| PALO ALTO INVESTORS LP | 08/19/2026 | 5.30 M | $22.03 M | -16.59% | 1.18% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 5.10 M | $21.20 M | -41.82% | 1.13% |
| NUVEEN, LLC | 08/11/2026 | 5.00 M | $20.79 M | 36.37% | 1.11% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 4.99 M | $20.77 M | -41.18% | 1.11% |
| MORGAN STANLEY | 08/13/2026 | 4.99 M | $20.74 M | -19.59% | 1.11% |
| JUPITER ASSET MANAGEMENT LTD | 08/10/2026 | 4.54 M | $18.87 M | 100.00% | 1.01% |
| JANE STREET GROUP, LLC | 08/14/2026 | 4.39 M | $18.28 M | 5.27% | 0.98% |
| NORTHERN TRUST CORP | 08/13/2026 | 4.15 M | $17.28 M | 44.47% | 0.92% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2026 | 3.87 M | $16.10 M | 519.96% | 0.86% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 3.25 M | $13.51 M | 56.72% | 0.72% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 3.22 M | $13.39 M | 15.66% | 0.72% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 3.22 M | $13.39 M | 100.00% | 0.72% |
| HRT FINANCIAL LP | 08/14/2026 | 3.10 M | $12.89 M | -11.14% | 0.69% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 2.67 M | $11.10 M | 56.08% | 0.59% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 2.66 M | $11.05 M | -11.35% | 0.59% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 2.54 M | $10.58 M | 16.42% | 0.56% |
| JPMORGAN CHASE & CO | 08/12/2026 | 2.43 M | $10.24 M | -2.76% | 0.54% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 2.42 M | $10.05 M | -23.73% | 0.54% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 2.39 M | $9.95 M | 20.10% | 0.53% |
| D. E. SHAW & CO., INC. | 08/14/2026 | 2.14 M | $8.92 M | -73.27% | 0.48% |
| CITADEL ADVISORS LLC | 09/02/2026 | 2.10 M | $8.76 M | -19.39% | 0.47% |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 08/14/2026 | 2.10 M | $8.74 M | 0.00% | 0.47% |
| ORION INVESTMENT CO | 08/11/2026 | 2.07 M | $8.62 M | 0.37% | 0.46% |
| XCELSIOR ADVISOR PARTNERS LLC | 08/14/2026 | 1.78 M | $7.42 M | 12,507.24% | 0.40% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 08/13/2026 | 1.71 M | $7.09 M | -17.03% | 0.38% |
| KNOTT DAVID M JR | 08/12/2026 | 1.60 M | $6.66 M | 0.00% | 0.36% |
| RICE HALL JAMES & ASSOCIATES, LLC | 08/07/2026 | 1.54 M | $6.41 M | 1.65% | 0.34% |
| B GROUP, INC. | 08/14/2026 | 1.50 M | $6.24 M | 0.00% | 0.33% |
| INVENOMIC CAPITAL MANAGEMENT LP | 08/14/2026 | 1.48 M | $6.17 M | -82.55% | 0.33% |
| WOODLINE PARTNERS LP | 08/14/2026 | 1.36 M | $5.67 M | 5.51% | 0.30% |
| FMR LLC | 08/13/2026 | 1.36 M | $5.64 M | 2,649.19% | 0.30% |
| UBS GROUP AG | 08/13/2026 | 1.29 M | $5.37 M | -32.61% | 0.29% |
| INVESCO LTD. | 08/14/2026 | 1.29 M | $5.35 M | -9.64% | 0.29% |
| C WORLDWIDE GROUP HOLDING A/S | 08/04/2026 | 1.26 M | $5.24 M | 0.00% | 0.28% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 1.16 M | $4.83 M | 21.46% | 0.26% |
| MIRADOR CAPITAL PARTNERS LP | 07/07/2026 | 1.08 M | $4.49 M | 0.66% | 0.24% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 08/14/2026 | 1.06 M | $4.39 M | 15.43% | 0.23% |
| SECTOR GAMMA AS | 08/12/2026 | 968.47 K | $4.03 M | 7.61% | 0.22% |
| CITIGROUP INC | 08/03/2026 | 882.13 K | $3.67 M | 979.39% | 0.20% |
| DEUTSCHE BANK AG\ | 08/07/2026 | 854.97 K | $3.56 M | 16.33% | 0.19% |
| JUMP FINANCIAL, LLC | 08/13/2026 | 825.90 K | $3.44 M | 3,312.82% | 0.18% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Iovance Biotherapeutics Inc institutional Ownership - FAQ's
During the previous two years, 408 institutional investors and hedge funds held shares of Iovance Biotherapeutics Inc. The most heavily invested institutionals were:
BlackRock, Inc.: 36.96 M
MHR FUND MANAGEMENT LLC: 28.97 M
STATE STREET CORP: 24.48 M
TWO SIGMA INVESTMENTS, LP: 19.01 M
VANGUARD CAPITAL MANAGEMENT LLC: 18.2 M
VANGUARD PORTFOLIO MANAGEMENT LLC: 14.39 M
64.37% of Iovance Biotherapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 355.92 M shares in the last 24 months. This purchase volume represents approximately $1.93 B in transactions.